Evidence map›Paper›PMID 31266056›Full record

Trial reportPloS one2019

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

Markus Riegersperger, Max Plischke, Anita Jallitsch-Halper, Corinna Steinhauser, Manuela Födinger, Wolfgang C Winkelmayer, Daniela Dunkler, Gere Sunder-Plassmann

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03751332 (The Vienna Prograf and Endothelial Progenitor Cell Extension Study), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03751332 phase4completednot on this map

The Vienna Prograf and Endothelial Progenitor Cell Extension Study

TypeinterventionalSponsorMedical University of ViennaRan2008 to 2010Enrolled87ConditionsImmunosuppression, Renal FailureArmsTacrolimus
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Markus RiegerspergerDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.ORCID 0000-0002-1151-9049
Max PlischkeDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.
Anita Jallitsch-HalperDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.
Corinna SteinhauserDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.
Manuela FödingerDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.
Wolfgang C WinkelmayerBaylor College of Medicine, Section of Nephrology, Department of Medicine, Baylor Clinic, Houston, Texas, United States of America.
Daniela DunklerCenter for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Austria, Europe.
Gere Sunder-PlassmannDivision of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.
Medical University of Vienna · ATBaylor College of Medicine · USKlinik Hietzing · ATSigmund Freud Privatuniversität Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

trial registrationPEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.

Indexed as

AgedATP Binding Cassette Transporter, Subfamily BBiopsyCyclosporineFemaleGenetic Association StudiesGenotypeGlomerular Filtration RateGraft RejectionHumansImmunosuppressive AgentsKidney TransplantationMaleMiddle AgedTacrolimusTissue DonorsABCB1 protein, humanATP Binding Cassette Transporter, Subfamily BCyclosporineImmunosuppressive AgentsTacrolimus

Identifiers

PMID31266056
PMCPMC6606311
OpenAlexW2956026690

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.